Details for Patent: 12,083,087
✉ Email this page to a colleague
Which drugs does patent 12,083,087 protect, and when does it expire?
Patent 12,083,087 protects COMBOGESIC IV and is included in one NDA.
This patent has thirty-two patent family members in twenty-five countries.
Drugs Protected by US Patent 12,083,087
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | COMBOGESIC IV | acetaminophen; ibuprofen sodium | SOLUTION;INTRAVENOUS | 215320-001 | Oct 17, 2023 | RX | Yes | Yes | 12,083,087 | ⤷ Subscribe | METHOD OF TREATING MILD TO MODERATE PAIN IN ADULTS | ⤷ Subscribe | ||||
| Hikma | COMBOGESIC IV | acetaminophen; ibuprofen sodium | SOLUTION;INTRAVENOUS | 215320-001 | Oct 17, 2023 | RX | Yes | Yes | 12,083,087 | ⤷ Subscribe | METHOD OF TREATING MODERATE TO SEVERE PAIN IN ADULTS AS AN ADJUNCT TO OPIOID ANALGESICS | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,083,087
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 100365 | ⤷ Subscribe | |||
| Australia | 2015289035 | ⤷ Subscribe | |||
| Brazil | 112017001093 | ⤷ Subscribe | |||
| Canada | 2955557 | ⤷ Subscribe | |||
| China | 106794163 | ⤷ Subscribe | |||
| China | 113018258 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
